Standard InChI: InChI=1S/C43H56N10O5/c1-4-31(27-54)46-37-23-38(53-40(48-37)34(25-45-53)28(2)3)44-24-29-12-14-32(15-13-29)47-43(58)51-21-19-50(20-22-51)18-7-5-6-9-30-10-8-11-33-35(30)26-52(42(33)57)36-16-17-39(55)49-41(36)56/h8,10-15,23,25,28,31,36,44,54H,4-7,9,16-22,24,26-27H2,1-3H3,(H,46,48)(H,47,58)(H,49,55,56)/t31-,36?/m0/s1
Standard InChI Key: YAEBZMQWNHWNAG-BRKUKBBPSA-N
Associated Targets(Human)
MDA-MB-468 9477 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
BT-549 31254 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MDA-MB-231 73002 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Protein cereblon/CDK9 113 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Protein cereblon/Cyclin-dependent kinase 1 7 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Protein cereblon/Cyclin-dependent kinase 2 25 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Protein cereblon/Cyclin-dependent kinase 4 68 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Protein cereblon/Cyclin-dependent-like kinase 5 8 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Protein cereblon/Cyclin-dependent kinase 6 113 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Protein cereblon/Cyclin-dependent kinase 7 8 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Cereblon/GSPT1 159 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Tumour 13 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Unknown
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 792.99
Molecular Weight (Monoisotopic): 792.4435
AlogP: 4.97
#Rotatable Bonds: 16
Polar Surface Area: 176.54
Molecular Species: NEUTRAL
HBA: 11
HBD: 5
#RO5 Violations: 2
HBA (Lipinski): 15
HBD (Lipinski): 5
#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.60
CX Basic pKa: 7.64
CX LogP: 4.19
CX LogD: 3.76
Aromatic Rings: 4
Heavy Atoms: 58
QED Weighted: 0.08
Np Likeness Score: -0.76
References
1.Wei D, Wang H, Zeng Q, Wang W, Hao B, Feng X, Wang P, Song N, Kan W, Huang G, Zhou X, Tan M, Zhou Y, Huang R, Li J, Chen XH.. (2021) Discovery of Potent and Selective CDK9 Degraders for Targeting Transcription Regulation in Triple-Negative Breast Cancer., 64 (19.0):[PMID:34538051][10.1021/acs.jmedchem.1c01350]